M, S. K., Katamreddy, J. D. and P, J. R. (2018) “A review on ANDA submission requirements for Generic drugs: ‘Paragraph IV certification’ as per FDA CDER guidelines”, International Journal of Drug Regulatory Affairs, 6(3), pp. 5-12. doi: 10.22270/ijdra.v6i3.260.